AL-15469A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AL-15469A, covering 2009-09-29 to 2016-11-18. Get the full timeline:
Most recent: Clinical Trial Update: AL-15469A for the Treatment of Bacterial Conjunctivitis [Phase 3]